AbbVie 2014 Annual Report Download - page 138
Download and view the complete annual report
Please find page 138 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128 -
129 -
130 -
131 -
132 -
133 -
134 -
135 -
136 -
137 -
138 -
139 -
140 -
141 -
142 -
143 -
144 -
145 -
146 -
147 -
148 -
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
 |
 |
13NOV201221352027
Securities Ownership of Principal Stockholders
................................................................................................................................................................................................................................................................................................................................................................................................
The table below reports the number of shares of AbbVie common stock beneficially owned as of December 31,
2014 by BlackRock, Inc., Capital Research Global Investors and The Vanguard Group (directly or through subsidiaries),
respectively, the only persons known to AbbVie to own beneficially more than 5% of AbbVie’s outstanding common
stock. It is based on information contained in Schedules 13G filed with the Securities and Exchange Commission by
BlackRock, Inc. on February 9, 2015, by Capital Research Global Investors on February 13, 2015, and by The Vanguard
Group on February 10, 2015. BlackRock, Inc. reported that it had sole voting power with respect to 97,202,991 shares,
shared voting power with respect to 18,417 shares, sole dispositive power with respect to 114,430,028 shares and
shared dispositive power with respect to 22,987 shares. Capital Research Global Investors reported that it had sole voting
and sole dispositive power with respect to 100,552,589 shares. The Vanguard Group reported that it had sole voting
power with respect to 2,754,958 shares, sole dispositive power with respect to 86,236,459 shares and shared dispositive
power with respect to 2,606,938 shares.
BlackRock, Inc. 114,453,015 7.2%
40 East 52nd Street
New York, NY 10022
Capital Research Global Investors 100,552,589 6.3%
333 South Hope Street
55th Floor
Los Angeles, CA 90071
The Vanguard Group 88,843,397 5.57%
100 Vanguard Boulevard
Malvern, PA 19355
18 2015 Proxy Statement
Name and Address of Beneficial Owner Shares Beneficially Owned Percent of Class
SECURITIES OWNERSHIP